Ose Immunotherapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ose immunotherapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ose Immunotherapeutics Today - Breaking & Trending Today

AbbVie To Receive Global License To Develop OSE-230 From OSE Immunotherapeutics

AbbVie Inc. (ABBV) and OSE Immunotherapeutics SA announced a strategic partnership to develop OSE-230, a monoclonal antibody designed to resolve chronic and severe inflammation, currently in the pre-clinical development stage. ....

Abbvie Inc , More Such Health News , Ose Immunotherapeutics ,

OSE Immunotherapeutics Reports on its 2023 Combined General Shareholder's Meeting Seite 1

22.06.2023 - Regulatory News: OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) today announced that all the resolutions submitted to a vote at the Combined General Shareholders’ Meeting were approved as proposed by OSE Immunotherapeutics’ Board of . Seite 1 ....

United States , Nicolas Poirier , Eric Leire , Jean Patrick Demonsang , Dominique Costantini , Maryvonne Hiance , Anne Laure Autret Cornet , Combined Shareholder Meeting , Chief Executive Officer , Financial Officer , Laure Autret Cornet , Chief Financial , Ose Immunotherapeutics ,

OSE Immunotherapeutics Presents Clinical Abstracts on Tedopi at the ASCO 2023 Annual Meeting

06.06.2023 - Regulatory News: OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) presented a poster and a publication in abstract book featuring Tedopi, an immunotherapy activating tumor specific T-cells, in non-small cell lung cancer (NSCLC) and in . Seite 1 ....

Gustave Roussy , Tedopi Atalante , Benjamin Besse , Principal Investigator , Performance Status , Ose Immunotherapeutics ,

OSE Immunotherapeutics' Board of Directors Proposes the Appointment of Eric Leire, MD, as New Independent Director Seite 1

31.05.2023 - Regulatory News: OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) today announced that the Board of Directors, upon the proposal of the Nomination and Remuneration Committee, has proposed Eric Leire, MD, as an independent Director of the . Seite 1 ....

France General , Nicolas Poirier , Enochian Biosciences , Eric Leire , Sceaux University , Doctor Grenoble University , Kellogg Graduate School Of Management Chicago , Genflow Biosciences Ltd , Schering Plough , Chief Executive , Chief Executive Officer , Dandrit Biotech , Boots Pharma , Medwell Capital , Biofund Venture , Medical Doctor , Grenoble University , Kellogg Graduate School , General Shareholder Meeting , Ose Immunotherapeutics ,

OSE Immunotherapeutics Presents Clinical and Preclinical Data from its Immuno-Oncology Portfolio

18.04.2023 - Regulatory News: OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) announces three presentations at the American Association for Cancer Research (AACR) Annual Meeting in Orlando (Florida), April 14-19, 2023. The presentations include the . Seite 1 ....

United States , Nicolas Poirier , Chief Executive Officer , Myeloid Derived Suppressor Cells , Ose Immunotherapeutics ,